The use of GLP-1 receptor agonists corresponded with a lower risk for depression among older adults with type 2 diabetes compared with dipeptidyl peptidase 4 inhibitors, results of a target trial emulation study suggested.GLP-1s did not reduce the risk for depression compared with sodium-glucose cotransporter 2 (SGLT2) inhibitors, another frequently prescribed diabetes treatment, according to
A day after offering Canada a one-month reprieve on punishing nearly across-the-board 25% tariffs, President Donald Trump has threatened new tariffs as soon as Friday…
Bayer told several brokerages about plans to seek shareholder permission to issue shares one day before formally announcing the news on Friday, which weighed heavily…
After screening 20,000 protein-encoding genes in the human body, Stanford researchers have identified a naturally occurring molecule that works like semaglutide, most popularly known as…
DARPA has launched a new prototype warship for the US Navy that not only won’t need any sailors, it can’t even accommodate them. The 180-ft…
Back in the 1960s, it seemed like better communications could solve all our problems. Don’t blame technology for the failure of that dream, says Annalee…
Background The health benefits of physical activity, including walking, are well-established, but the relationship between daily step count and mortality in hypertensive populations remains underexplored.…
Brazil’s Sao Paulo state confirmed on Friday a case of the new mpox strain, the first case of clade Ib mpox in the region, it…
Even as large language models (LLMs) become ever more sophisticated and capable, they continue to suffer from hallucinations: offering up inaccurate information, or, to put…
Guest Co-Editors: Regina Wright, PhD, FGSA (University of Delaware, USA) and Samuele Zilioli, PhD (Wayne State University, USA).
